Pimecrolimus 1% cream for the treatment of rosacea

Journal of Dermatology

Volumn 38, Issue 12, 2011, Pages 1135-1139

  Kim, Moon Bum ^a,b   Kim, Gun Wook ^a   Park, Hyun Je ^a   Kim, Hoon Soo ^a   Chin, Hyun Woo ^a   Kim, Su Han ^a   Kim, Byung Soo ^a,b   Ko, Hyun Chang ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

calcineurin inhibitor; pimecrolimus; rosacea

Indexed keywords

PIMECROLIMUS;

ADULT; ARTICLE; BURN; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; FEMALE; HUMAN; MALE; OPEN STUDY; PHOTOGRAPHY; PRURITUS; ROSACEA; SCORING SYSTEM; SKIN DISEASE; SKIN STINGING;

ADMINISTRATION, TOPICAL; CALCINEURIN; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ROSACEA; TACROLIMUS; TREATMENT OUTCOME;

EID: 81855185599     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01223.x     Document Type: Article

References (21)

1. Powell FC,. Clinical practice. Rosacea. N Engl J Med 2005; 352: 793-803.
2. Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907-912.
3. Yamasaki K, Gallo RL,. The molecular pathology of rosacea. J Dermatol Sci 2009; 55: 77-81.
4. Crawford GH, Pelle MT, James WD,. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-341; quiz 42-44.
5. Heymann WR,. Rosacea subtype-directed therapy. J Am Acad Dermatol 2004; 51: 90-92.
6. Grassberger M, Steinhoff M, Schneider D, Luger TA,. Pimecrolimus-an anti-inflammatory drug targeting the skin. Exp Dermatol 2004; 13: 721-730.
7. Gupta AK, Chow M,. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17: 493-503.
8. Crawford KM, Russ B, Bostrom P,. Pimecrolimus for treatment of acne rosacea. Skinmed 2005; 4: 147-150.
9. Cunha PR, Rossi AB,. Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. Acta Derm Venereol 2006; 86: 71-72.
10. Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007; 156: 728-732.
11. Gul U, Gonul M, Kilic A, et al. A case of granulomatous rosacea successfully treated with pimecrolimus cream. J Dermatolog Treat 2008; 19: 313-315.
12. Karabulut AA, Izol Serel B, Eksioglu HM,. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. J Eur Acad Dermatol Venereol 2008; 22: 729-734.
13. Koca R, Altinyazar HC, Ankarali H, Muhtar S, Tekin NS, Cinar S,. A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial. Clin Exp Dermatol 2010; 35: 251-256.
14. Chu CY,. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol 2007; 21: 484-490.
15. Thiboutot D, Thieroff-Ekerdt R, Graupe K,. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003; 48: 836-845.
16. Pelle MT, Crawford GH, James WD,. Rosacea: II. Therapy. J Am Acad Dermatol 2004; 51: 499-512; quiz 3-4.
17. Wellington K, Noble S,. Pimecrolimus: a review of its use in atopic dermatitis. Am J Clin Dermatol 2004; 5: 479-495.
18. Lee DH, Li K, Suh DH,. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. Br J Dermatol 2008; 158: 1069-1076.
19. Chu CY,. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 2005; 152: 396-399.
20. Gorman CR, White SW,. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. Arch Dermatol 2005; 141: 1168.
21. El Sayed F, Ammoury A, Dhaybi R, Bazex J,. Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 2006; 54: 548-550.